Pancreas Female 60-69 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with Pancreas Female 60-69 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with Pancreas Female 60-69 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with Pancreas Female 60-69 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Pancreas Female 60-69 Up.

Results found

Linked to

 

Label

Description

 

Gene

glucagon like peptide 1 receptor

Gene

olfactory receptor family 8 subfamily D member 4

Gene

chymotrypsin like elastase 3A

Gene

CEA cell adhesion molecule 16, tectorial membrane component

Gene

pancreatic lipase

Gene

basic helix-loop-helix family member a15

Gene

glutamate rich 5

Gene

regenerating family member 3 gamma

Gene

G protein-coupled receptor 150

Gene

nuclear receptor subfamily 5 group A member 2

  • Gene

    glucagon like peptide 1 receptor


  • Gene

    olfactory receptor family 8 subfamily D member 4


  • Gene

    chymotrypsin like elastase 3A


  • Gene

    CEA cell adhesion molecule 16, tectorial membrane component


  • Gene

    pancreatic lipase


  • Gene

    basic helix-loop-helix family member a15


  • Gene

    glutamate rich 5


  • Gene

    regenerating family member 3 gamma


  • Gene

    G protein-coupled receptor 150


  • Gene

    nuclear receptor subfamily 5 group A member 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.